IID00304
Transcriptional coactivator YAP1 (Homo sapiens) P46937
:order :disorder :conflict :PDB cluster :ProS :SCOP Domain :Pfam Domain
Experiment
504
fasta
order/disorder by at least rule
disorder by at least rule
order/disorder by majority rule
Seq 50-171 Hetero dimer : IID00547Complex
Region 4re1 C 50-99 order
Region 4re1 C 100-171 disorder
Region 4re1 D 50-52 disorder
Region 4re1 D 53-99 order
Region 4re1 D 100-171 disorder
Region 3kys D 50-51 disorder
Region 3kys D 52-100 order
Region 3kys D 101-171 disorder
Region 3kys B 50-100 order
Region 3kys B 101-171 disorder
Seq 60-100 Hetero dimer : Q15561
Region 5oaq L 60-99 order
Region 5oaq L 100-100 disorder
Seq 124-133 Hetero dimer : IID00301Complex
Region 3mhr P 124-133 order
Seq 165-204 Hetero dimer :
Region 1k9q A 165-204 order
Region 1k9q A 165-170 high_rmsd
Seq 165-204 Hetero dimer :
Region 1k9r A 165-204 order
Region 1k9r A 165-170 high_rmsd
Region 1k9r A 204-204 high_rmsd
Region 4rex A 165-208 order
Region 4rex A 209-209 disorder
Seq 165-210 Hetero dimer : Q96G27
Region 1k5r A 165-204 order
Region 1k5r A 165-171 high_rmsd
Region 1k5r A 203-204 high_rmsd
Region 1jmq A 165-210 order
Region 1jmq A 165-165 high_rmsd
Region 1jmq A 208-210 high_rmsd
Seq 170-205 Hetero dimer : IID00174Complex
Region 2lay A 170-205 order
Region 2lax A 170-205 order
Seq 170-205 Hetero dimer : IID00135Complex
Region 2ltw A 170-205 order
Seq 230-263 Hetero dimer : IID00174Complex
Region 2law A 230-263 order
Seq 230-265 Hetero dimer : IID00135Complex
Region 2ltv A 230-265 order
SeqProS verified 124-133 Hetero dimer : IID00301Complex
Region 3mhr P 124-133 order
Region 3kys D 101-171 disorder
412-412 Phosphothreonine; by MAPK8 and MAPK9
403-403 Phosphoserine; by CK1
407-407 Phosphotyrosine; by ABL1
400-400 Phosphoserine; by CK1
397-397 Phosphoserine; by LATS1 and LATS2
367-367 Phosphoserine; by MAPK8 and MAPK9
164-164 Phosphoserine; by LATS1 and LATS2
138-138 Phosphoserine; by MAPK8 and MAPK9
154-154 Phosphothreonine; by MAPK8 and MAPK9
127-127 Phosphoserine; by LATS1 and LATS2
119-119 Phosphothreonine; by MAPK8 and MAPK9
109-109 Phosphoserine; by LATS1 and LATS2
61-61 Phosphoserine; by LATS1 and LATS2
412-412 Phosphothreonine; by MAPK8 and MAPK9
407-407 Phosphotyrosine; by ABL1
403-403 Phosphoserine; by CK1
400-400 Phosphoserine; by CK1
397-397 Phosphoserine; by LATS1 and LATS2
367-367 Phosphoserine; by MAPK8 and MAPK9
164-164 Phosphoserine; by LATS1 and LATS2
154-154 Phosphothreonine; by MAPK8 and MAPK9
138-138 Phosphoserine; by MAPK8 and MAPK9
127-127 Phosphoserine; by LATS1 and LATS2
119-119 Phosphothreonine; by MAPK8 and MAPK9
109-109 Phosphoserine; by LATS1 and LATS2
61-61 Phosphoserine; by LATS1 and LATS2
Prediction
Disorder 1-164,211-220,267-504
Known Domain 165-210,221-266
PF00397 173-202 6e-07 WW domain
PF00397 232-261 9e-08 WW domain
PF00397 173-202 1.6e-12 WW domain
PF00397 232-261 2.3e-14 WW domain